Pulsatile arterial blood pressure mimicking aortic valve opening during continuous-flow LVAD support: a case report.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
18 Dec 2019
Historique:
received: 23 09 2019
accepted: 03 12 2019
entrez: 20 12 2019
pubmed: 20 12 2019
medline: 14 3 2020
Statut: epublish

Résumé

Left ventricular assist devices (LVAD) have become a common treatment option in advanced heart failure. Lack of aortic valve opening during left ventricular unloading is a common complication and associated with a worse outcome. Maintaining a minimum pulse pressure is an important goal during the early postoperative period after LVAD implantation since it is commonly seen as secure sign of aortic valve opening. We report a case of an LVAD-supported patient with early permanent closure of the aortic valve despite a pulse pressure > 15 mmHg at all times following LVAD implantation. We demonstrate how careful assessment of the invasive arterial blood pressure curve can indicate aortic valve closure irrespective of pulsatile blood flow. A 69-year old male patient with terminal ischemic cardiomyopathy was referred for long-term mechanical circulatory support. Due to mild aortic regurgitation both an aortic bioprosthesis and a continuous-flow left ventricular assist device were implanted. Postoperative echocardiography documented a patent aortic bioprosthesis and an acceptable residual systolic left ventricular contractility. During invasive arterial blood pressure monitoring repetitive transient slight blood pressure decreases followed by slight blood pressure increases coincided with programmed LVAD flushing cycles. Permanent pulsatile flow with a pulse pressure of ≥15 mmHg conveyed systolic opening of the aortic valve. Echocardiography, however, proved early permanent aortic valve closure. In retrospect, transformation of the automated LVAD flushing cycles into visible changes of the arterial blood pressure curve during invasive blood pressure monitoring is indicative of ejection of the complete cardiac output through LVAD itself, and therefore an early clinical sign of aortic valve closure. We present this interesting didactic case to highlight caveats during the early postoperative period after LVAD implantation. Moreover, this case demonstrates that careful and differentiated observation of the arterial blood pressure waveform provides crucial information in this unique and growing patient population of continuous-flow LVAD support.

Sections du résumé

BACKGROUND BACKGROUND
Left ventricular assist devices (LVAD) have become a common treatment option in advanced heart failure. Lack of aortic valve opening during left ventricular unloading is a common complication and associated with a worse outcome. Maintaining a minimum pulse pressure is an important goal during the early postoperative period after LVAD implantation since it is commonly seen as secure sign of aortic valve opening.
AIMS/OBJECTIVE OBJECTIVE
We report a case of an LVAD-supported patient with early permanent closure of the aortic valve despite a pulse pressure > 15 mmHg at all times following LVAD implantation. We demonstrate how careful assessment of the invasive arterial blood pressure curve can indicate aortic valve closure irrespective of pulsatile blood flow.
METHOD METHODS
A 69-year old male patient with terminal ischemic cardiomyopathy was referred for long-term mechanical circulatory support. Due to mild aortic regurgitation both an aortic bioprosthesis and a continuous-flow left ventricular assist device were implanted. Postoperative echocardiography documented a patent aortic bioprosthesis and an acceptable residual systolic left ventricular contractility. During invasive arterial blood pressure monitoring repetitive transient slight blood pressure decreases followed by slight blood pressure increases coincided with programmed LVAD flushing cycles. Permanent pulsatile flow with a pulse pressure of ≥15 mmHg conveyed systolic opening of the aortic valve. Echocardiography, however, proved early permanent aortic valve closure. In retrospect, transformation of the automated LVAD flushing cycles into visible changes of the arterial blood pressure curve during invasive blood pressure monitoring is indicative of ejection of the complete cardiac output through LVAD itself, and therefore an early clinical sign of aortic valve closure.
DISCUSSION/CONCLUSION CONCLUSIONS
We present this interesting didactic case to highlight caveats during the early postoperative period after LVAD implantation. Moreover, this case demonstrates that careful and differentiated observation of the arterial blood pressure waveform provides crucial information in this unique and growing patient population of continuous-flow LVAD support.

Identifiants

pubmed: 31852537
doi: 10.1186/s13019-019-1039-z
pii: 10.1186/s13019-019-1039-z
pmc: PMC6921524
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

219

Références

N Engl J Med. 2009 Dec 03;361(23):2241-51
pubmed: 19920051
J Heart Lung Transplant. 2016 Aug;35(8):973-5
pubmed: 27519787
Circ J. 2015;79(1):104-11
pubmed: 25381791
Circulation. 2012 Mar 13;125(10):1304-15
pubmed: 22412091
J Heart Lung Transplant. 2010 Dec;29(12):1321-9
pubmed: 20674397
J Rehabil Assist Technol Eng. 2017 Sep 01;4:2055668317725994
pubmed: 31186935
ASAIO J. 2014 Mar-Apr;60(2):183-8
pubmed: 24399060
J Heart Lung Transplant. 2009 Jun;28(6):535-41
pubmed: 19481012
ASAIO J. 2017 Jul/Aug;63(4):425-432
pubmed: 28118265
Ann Thorac Surg. 2011 Sep;92(3):929-34
pubmed: 21871279
Curr Heart Fail Rep. 2014 Mar;11(1):103-10
pubmed: 24193452
J Heart Lung Transplant. 2009 May;28(5):423-7
pubmed: 19416768
Tex Heart Inst J. 2014 Apr 01;41(2):115-20
pubmed: 24808767

Auteurs

Matthias Paprotny (M)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Frank Ruschitzka (F)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Bernd Lüders (B)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Markus J Wilhelm (MJ)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Raed Aser (R)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Dominique Bettex (D)

Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland.

Andreas J Flammer (AJ)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.

Alain Rudiger (A)

Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland.

Stephan Winnik (S)

University Heart Center Zurich, University Hospital Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. stephan.winnik@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH